Beaumont Financial Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1957394 NEEDHAM, MA

Position in AMGN

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,495,555

+$32,211 QoQ

Shares Held

4,130

-0.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,432

of 3,140 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Beaumont Financial Advisors, LLC holds $40,048,849 across 7 Drug Manufacturers - General names. AMGN ranks #5 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	111,216	$28,245,527
2	LLY	ELI LILLY & Co	4,760	$5,709,287
3	MRK	Merck & Co., Inc.	15,195	$1,952,557
4	ABBV	AbbVie Inc.	7,660	$1,927,562
5	AMGN	Amgen Inc This page	4,130	$1,495,555
6	BMY	Bristol Myers Squibb Co	8,606	$495,877
7	GILD	Gilead Sciences, Inc.	1,761	$222,484

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,495,555	4,130	-0.7%	Shares	Sole	2026-08-04
2026-03-31	$1,463,344	4,159	-2.4%	Shares	Sole	2026-05-05
2025-12-31	$1,394,340	4,260	+1.2%	Shares	Sole	2026-01-16
2025-09-30	$1,187,497	4,208	+0.1%	Shares	Sole	2025-10-23
2025-06-30	$1,174,078	4,205	-1.7%	Shares	Sole	2025-07-16
2025-03-31	$1,332,810	4,278	-3.2%	Shares	Sole	2025-05-12
2024-12-31	$1,152,289	4,421	+3.9%	Shares	Sole	2025-01-17
2024-09-30	$1,371,647	4,257	-9.5%	Shares	Sole	2024-10-09
2024-06-30	$1,470,077	4,705	-1.2%	Shares	Sole	2024-07-24
2024-03-31	$1,353,931	4,762	+0.1%	Shares	Sole	2024-05-10
2023-12-31	$1,370,111	4,757	+1.0%	Shares	Sole	2024-01-31
2023-09-30	$1,265,590	4,709	+7.8%	Shares	Sole	2023-11-01
2023-06-30	$969,783	4,368	+1.7%	Shares	Sole	2023-08-02
2023-03-31	$1,038,558	4,296	-5.3%	Shares	Sole	2023-05-08
2022-12-31	$1,191,597	4,537	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.